Pharmacies are still turning people away as the Adderall shortage continues

Catch up with NBC News Clone on today's hot topic: Adderall Shortage Pharmacies Still Unable Stock Enough Drug Patients Rcna80260 - Health and Medicine | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

Despite improvements in availability, some pharmacists still struggle to keep the medication in stock.
Get more newsAdderall Shortage Pharmacies Still Unable Stock Enough Drug Patients Rcna80260 - Health and Medicine | NBC News Cloneon

Seven months into the nationwide shortage of Adderall, pharmacist Steve Moore still gets phone calls every day from people with ADHD asking whether he has the medication in stock. He’ll occasionally get out-of-town visitors, too.

“It’s a pretty far drive,” said Moore, who owns Condo Pharmacy in Plattsburgh, New York, a small city just south of the Canadian border.

But Moore has to turn them away. Some doses aren’t expected to be available until mid-May at the earliest, a month later than earlier estimates, according to the Food and Drug Administration’s drug shortage database. 

“Obviously, I want to help everybody I can,” Moore said, “but if I know I’ve got three patients who need this particular product, I’m really trying to make sure that the patients we know are coming in have what they need.”

The FDA first confirmed a nationwide shortage of Adderall in October, after a surge in demand for the attention deficit/hyperactivity disorder drug during the coronavirus pandemic. Although supply problems have improved since then, some pharmacies say they are still unable to keep the drug or its generic versions in stock. 

The supply problem means people with ADHD who need the drug are forced to turn to different medications or wait several weeks to get their prescriptions.

“We mainly receive calls from people asking if we have the medication in stock, and we have to tell them that we don’t,” said Mike Koelzer, a pharmacist and the owner of Kay Pharmacy in Grand Rapids, Michigan. 

Koelzer said the shortage has hurt his business financially because he doesn’t have enough supply for his regular customers, forcing them to seek the drug elsewhere. 

Sometimes his pharmacy will provide other ADHD medications, but even those medications, like Ritalin, are in short supply too. 

People are often frustrated and worried, Koelzer added, when they aren’t able to find the medication they need. 

“We don’t have good answers for them other than to keep checking back or to try another pharmacy,” he said. “It’s been a difficult situation for both us and our customers.”

How long will the shortage last?

The supply problem could persist for few more weeks or longer. According to the FDA’s drug shortage database, some doses of a generic version of Adderall, from the drugmaker Alvogen, are expected to be in short supply until later this month or mid-May. Granules Pharmaceuticals, another generic manufacturer of Adderall, isn’t expected to have it available until May, according to the agency.

Teva Pharmaceuticals, the country’s largest supplier of the brand name Adderall, said in a statement that it isn’t experiencing manufacturing issues or shortages but noted that some pharmacies and patients in the U.S. could experience “intermittent delays” in getting the medication. NBC News has reached out to all 10 companies that list shortages of the drug in the FDA database. 

Michael Ganio, the senior director of pharmacy practice at the American Society of Health-System Pharmacists, which tracks drug shortages, said the organization first heard about the supply problems for Adderall about a year ago.

Bottles of Adderall XR at a pharmacy in Remington, Va., on Feb. 26, 2019.
Bottles of Adderall XR at a pharmacy in Remington, Va., on Feb. 26, 2019.Kristoffer Tripplaar / Sipa USA via AP file

At the time, he said, manufacturers attributed the issue to a lack of workers, and since then, they have tried to ramp up production, to varying results. 

Further complicating matters is that Adderall is a controlled substance regulated by the Drug Enforcement Administration, which sets limits on how much of the active ingredient drugmakers are allowed to produce in a given time frame. Drugmakers must get approval from the DEA before they go over their quotas, he said.

“It is very difficult to evaluate the increase in demand, which has been a challenge for manufacturers,” he said, adding that some drugmakers have paused selling the drugs to new customers.

In the meantime, pharmacies are adapting. CVS Health and Walgreens said they are aware of the shortages and are continuing to work with suppliers or patients to help meet the demand.

“Our pharmacists will work with patients who are prescribed this medication as needed,” Matt Blanchette, a spokesperson for CVS Health, said in a statement. 

Other pharmacies will have to keep turning patients away.

Benjamin Jolley, a pharmacist and the manager of Jolley’s Compounding Pharmacy in Salt Lake City, said the pharmacy isn't taking on any new customers.

He was able to buy 10 bottles of Adderall on Wednesday morning, the first time he had been able to buy it in two weeks.

“The wholesaler texted me and said: ‘Hey, we’ve got some if you want it. Go buy it right now.’”

The purchase means the dozen or so people who get the medication at his pharmacy will be able to get their prescriptions filled.

"It's a hard-to-come-by product," Jolley said.

Follow NBC HEALTH on Twitter & Facebook.

AdBlock Detected!
Please disable it to support our content.
×

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Joe Biden Campaign News - Politics and Government | NBC News Clone | Kamala Harris Vp Announcement - Politics and Government | NBC News Clone | Trump Indictment Latest - Politics and Government | NBC News Clone | Election Results Live - Politics and Government | NBC News Clone | Swing States Polling - Politics and Government | NBC News Clone | Debate Highlights - Politics and Government | NBC News Clone | Budget Approval 2025 - Politics and Government | NBC News Clone | Abortion Ruling - Politics and Government | NBC News Clone | Us China Relations - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Federal Reserve Interest Rates - Business and Economy | NBC News Clone | Stock Market Today - Business and Economy | NBC News Clone | Recession Prediction 2025 - Business and Economy | NBC News Clone | Jobs Report Unemployment - Business and Economy | NBC News Clone | Ai Stock Surge - Business and Economy | NBC News Clone | Housing Market Crash - Business and Economy | NBC News Clone | Oil Prices Update - Business and Economy | NBC News Clone | Amazon Prime Sales - Business and Economy | NBC News Clone | Bitcoin Etf Approval - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Covid Variants Update - Health and Medicine | NBC News Clone | Boosters New Guidelines - Health and Medicine | NBC News Clone | Anxiety Depression Treatment - Health and Medicine | NBC News Clone | Longevity Research - Health and Medicine | NBC News Clone | Diet Trends 2025 - Health and Medicine | NBC News Clone | Workout Routines - Health and Medicine | NBC News Clone | Fda Approvals 2025 - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Israel Palestine War News - World News | NBC News Clone | China Taiwan Tensions - World News | NBC News Clone | Middle East Peace Talks - World News | NBC News Clone | European Union Politics - World News | NBC News Clone | Development News - World News | NBC News Clone | North Korea Missile Test - World News | NBC News Clone | Brazil Election - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | Google Bard Ai - Technology and Innovation | NBC News Clone | Ai Regulation Laws - Technology and Innovation | NBC News Clone | Tiktok Ban Update - Technology and Innovation | NBC News Clone | Data Breaches 2025 - Technology and Innovation | NBC News Clone | Iphone 16 Release - Technology and Innovation | NBC News Clone | Nasa Mars Mission - Technology and Innovation | NBC News Clone | Web3 Developments - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Super Bowl 2025 Preview - Sports and Recreation | NBC News Clone | Nba Playoffs 2025 - Sports and Recreation | NBC News Clone | Champions League Finals - Sports and Recreation | NBC News Clone | World Series 2025 - Sports and Recreation | NBC News Clone | Masters Tournament 2025 - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hurricane Season 2025 - Weather and Climate | NBC News Clone | Global Warming Report - Weather and Climate | NBC News Clone | Weekly Weather Update - Weather and Climate | NBC News Clone | Earthquake Alerts - Weather and Climate | NBC News Clone | Solar Storm Warning - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Oscar Nominations 2025 - Entertainment and Celebrity | NBC News Clone | Grammy Awards 2025 - Entertainment and Celebrity | NBC News Clone | Netflix New Releases - Entertainment and Celebrity | NBC News Clone | Video Game Releases - Entertainment and Celebrity | NBC News Clone | Bestseller List - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Political Corruption - Investigations and Analysis | NBC News Clone | Big Tech Monopoly - Investigations and Analysis | NBC News Clone | Data Privacy Scandal - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone | Nyc Mayor News - Local News and Communities | NBC News Clone | La Wildfires Update - Local News and Communities | NBC News Clone | Hurricane Preparedness - Local News and Communities | NBC News Clone